Divis Laboratories Share Price Today - Live Blog for September 26, 2025

Divis Laboratories Ltd witnessed a -0.06% decrease in its share price, and it is currently trading at ₹5,677.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 67.9000, an ROE of 14.6369% and a debt to equity ratio of 0.0003.

With a -0.84% decrease, Divis Laboratories Ltd's share price is now ₹5,660.10. Investors should examine the factors driving this decline. The stock's PE ratio is 67.9000, whereas the industry PE ratio stands at 34.9706.

The stock of Divis Laboratories Ltd is facing a -0.04% decline and is currently trading at ₹5,712.90 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Divis Laboratories Ltd shares experienced a -0.18% reduction, with the current market price at ₹5,712.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Divis Laboratories Ltd witnessed a substantial 0.18% increase in its share price and is currently trading at ₹5,728.75. This remarkable performance has caught the eye of investors.

Divis Laboratories Ltd's share price has experienced a notable 0.20% upswing, and it's currently trading at ₹5,713.60 per share. Investors are closely watching this development.

The share price of Divis Laboratories Ltd soared by an impressive 0.14%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹5,705.90 per share.

Divis Laboratories Ltd shares experienced a -0.04% reduction, with the current market price at ₹5,700.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Divis Laboratories Ltd has had quite the run lately, experiencing a substantial 0.02% uptick in its share price. As a result, it's now actively trading at ₹5,701.40 per share, making it an attractive option for investors.

In recent times, Divis Laboratories Ltd witnessed a decline of -0.26% in its share price, and it currently trades at ₹5,704.00 per share. The stock has an ROE of 14.6369% and debt to equity ratio of 0.0003.

Divis Laboratories Ltd shares experienced a -0.35% reduction, with the current market price at ₹5,719.40. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Divis Laboratories Ltd is facing a -0.14% decline and is currently trading at ₹5,739.45 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Divis Laboratories Ltd shares saw a -0.14% decrease, reaching a current market price of ₹5,739.45. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 67.9000, an ROE of 14.6369% and a debt to equity ratio of 0.0003.

Divis Laboratories Ltd observed a -0.24% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹5,736.55. The stock has a PE ratio of 67.9000, an ROE of 14.6369% and a debt to equity ratio of 0.0003.

Divis Laboratories Ltd observed a -0.24% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹5,736.55. The stock has a PE ratio of 67.9000, an ROE of 14.6369% and a debt to equity ratio of 0.0003.

Divis Laboratories Ltd shares experienced a -0.05% reduction, with the current market price at ₹5,747.05. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Divis Laboratories Ltd stock price decreased by -0.41%, with the current market value at ₹5,746.70 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Divis Laboratories Ltd's shares saw an increase of 0.08%, reaching the current market price of ₹5,770.35. This development underscores the stock's growing popularity.

Divis Laboratories Ltd experienced a -0.21% dip in its share price and is currently trading at ₹5,766.00. The stock has a PE ratio of 67.9000, an ROE of 14.6369% and a debt to equity ratio of 0.0003.

Divis Laboratories Ltd's share price has dropped by -0.07%, a development that warrants careful analysis. Presently trading at ₹5,778.20, investors are assessing whether this presents an opportunity or a risk.

Divis Laboratories Ltd's shares saw an increase of 0.01%, reaching the current market price of ₹5,791.00. This development underscores the stock's growing popularity.

Following a noteworthy 0.15% increase, Divis Laboratories Ltd's shares are now trading at ₹5,790.20. When it comes to valuation, this stock has a PE ratio of 67.9000, with the industry PE ratio at 34.9706.

Divis Laboratories Ltd's share price has fallen by -0.06%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹5,775.00, and market participants are assessing the implications. The stock has a PE ratio of 67.9000, an ROE of 14.6369% and a debt to equity ratio of 0.0003.

Divis Laboratories Ltd witnessed a -0.23% decrease in its share price, and it is currently trading at ₹5,783.05. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 67.9000, an ROE of 14.6369% and a debt to equity ratio of 0.0003.

Divis Laboratories Ltd share price surged by 0.71%. With its current market price standing at ₹5,796.60 per share, this stock is garnering increased attention from the investment community.

The stock of Divis Laboratories Ltd is making significant strides, boasting a 0.87% increase and currently trading at ₹5,756.00 per share. This upward trajectory is turning heads in the market.

The share price of Divis Laboratories Ltd has plummeted by -0.66%, signalling a challenging period. Currently trading at ₹5,693.20, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Divis Laboratories Ltd suffered a -2.15% drop, and it's now trading at ₹5,740.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.